ABBV: A Great Way to Play Healthcare’s Comeback

AbbVie's Humira is soon to be the world's No. 1 best-selling drug. And its growth prospects couldn't look better. More 

Biggest Movers in Healthcare Stocks Now – EXAS REGN AMGN CELG

Healthcare stocks rose broadly on Wall Street on Wednesday morning, with the sector seeing an overall increase of 0.7%. More 

Time for Markets to Rally On — Maybe (ABBV, JNJ, MCD)

Several recent rallies in the markets have investors seeing positive signs moving forward, although doubts remain. Here is where I stand. More 

10 Pharmaceutical Stocks to Buy for the Dividends

Surprise! This sliver of the healthcare sector not known for dishing out income serves up some decent dividend stocks. More 

7 Pharmaceutical Stocks to Buy Now

Seven pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

53 Stock Upgrades and Downgrades for the Week

My latest portfolio grader rankings will give you a road map for your next portfolio moves. Here are 53 stock upgrades and downgrades to start More 

8 Pharmaceutical Stocks to Buy Now

This week, eight pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More